ICAD Icad Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ICAD

Price (delayed)

$1.52

Market cap

$40.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.19

Enterprise value

$19.13M

iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection ...

Highlights
Icad's quick ratio has soared by 107% YoY and by 98% from the previous quarter
The net income has soared by 65% YoY and by 52% from the previous quarter
The equity has grown by 8% from the previous quarter but it has contracted by 4.3% YoY
ICAD's revenue is down by 15% QoQ and by 13% YoY
The gross profit has declined by 12% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.icadmed.com
Peers: FONR HOLX GE

Key stats

What are the main financial stats of ICAD
Market
Shares outstanding
26.54M
Market cap
$40.34M
Enterprise value
$19.13M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.2
Price to sales (P/S)
2.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
Earnings
Revenue
$17.32M
EBIT
-$4.81M
EBITDA
-$3.94M
Free cash flow
-$6.23M
Per share
EPS
-$0.19
Free cash flow per share
-$0.24
Book value per share
$1.27
Revenue per share
$0.68
TBVPS
$1.28
Balance sheet
Total assets
$41.42M
Total liabilities
$8M
Debt
$461,000
Equity
$33.42M
Working capital
$22.93M
Liquidity
Debt to equity
0.01
Current ratio
4.4
Quick ratio
4.16
Net debt/EBITDA
5.38
Margins
EBITDA margin
-22.8%
Gross margin
85.4%
Net margin
-28%
Operating margin
-44.4%
Efficiency
Return on assets
-10.8%
Return on equity
-15.3%
Return on invested capital
-64.2%
Return on capital employed
-13.9%
Return on sales
-27.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ICAD stock price

How has the Icad stock price performed over time
Intraday
-1.3%
1 week
-6.75%
1 month
-5%
1 year
6.29%
YTD
-14.12%
QTD
-5.59%

Financial performance

How have Icad's revenue and profit performed over time
Revenue
$17.32M
Gross profit
$14.79M
Operating income
-$7.69M
Net income
-$4.85M
Gross margin
85.4%
Net margin
-28%
The net income has soared by 65% YoY and by 52% from the previous quarter
The net margin has soared by 59% YoY and by 43% from the previous quarter
Icad's operating income has increased by 25% YoY and by 20% from the previous quarter
ICAD's revenue is down by 15% QoQ and by 13% YoY

Growth

What is Icad's growth rate over time

Valuation

What is Icad stock price valuation
P/E
N/A
P/B
1.2
P/S
2.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
The company's EPS has surged by 65% YoY and by 51% QoQ
ICAD's price to book (P/B) is 83% lower than its 5-year quarterly average of 7.0 and 14% lower than its last 4 quarters average of 1.4
The equity has grown by 8% from the previous quarter but it has contracted by 4.3% YoY
ICAD's P/S is 58% below its 5-year quarterly average of 5.4 but 2.3% above its last 4 quarters average of 2.2
ICAD's revenue is down by 15% QoQ and by 13% YoY

Efficiency

How efficient is Icad business performance
The company's return on sales has surged by 60% YoY and by 44% QoQ
ICAD's return on invested capital has surged by 57% year-on-year and by 46% since the previous quarter
Icad's return on assets has surged by 56% YoY and by 49% QoQ
The ROE has soared by 56% YoY and by 51% from the previous quarter

Dividends

What is ICAD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ICAD.

Financial health

How did Icad financials performed over time
Icad's quick ratio has soared by 107% YoY and by 98% from the previous quarter
The current ratio has soared by 55% from the previous quarter and by 55% YoY
The debt is 99% less than the equity
The debt to equity has dropped by 50% since the previous quarter and by 50% year-on-year
The debt has decreased by 31% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.